Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2019) 65 P205 | DOI: 10.1530/endoabs.65.P205

SFEBES2019 POSTER PRESENTATIONS Metabolism and Obesity (104 abstracts)

The American lifestyle induced obesity syndrome diet (ALIOS) in rodents recapitulates the clinical features and sexual dimorphism of NAFLD and NASH

Shelley Harris 1 , Anastasia Arvaniti 2 , Roger Cox 3 , Laura Gathercole 2 & Jeremy Tomlinson 1


1University of Oxford, Oxford, UK; 2Oxford Brookes University, Oxford, UK; 3MRC Harwell Institute, Didcot, UK


Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome, ranging from simple steatosis to the necro-inflammatory disease, non-alcoholic steatohepatitis (NASH). Development of NASH subsequently increases risk of hepatocellular carcinomas (HCC). Alongside the impact on the liver, NASH is associated with other clinical features, including insulin resistance, hyperlipidaemia and sarcopaenia. We demonstrate that mice fed the American lifestyle induced obesity syndrome diet (ALIOS) recapitulate many of the clinical characteristics of human NAFLD and NASH, making it a robust model for studying the condition. Male and female C57BL/6 mice were fed either normal chow (NC) or ALIOS (45% fat [30% trans-fat], 55% fructose: 45% glucose in H2O; n=15 in each group) for 52 weeks. ALIOS fed mice had increased body mass and were insulin resistant. Relative quadriceps mass was decreased in ALIOS fed mice, mirroring sarcopaenia observed in NAFLD patients. In addition, metabolic caging revealed that ALIOS fed males were more sedentary than females. Plasma cholesterol, AST and ALT progressively increased in mice fed ALIOS in both sexes over the duration of the study. Whilst the ALIOS diet initially increased hepatic triglyceride content, by 52 weeks, hepatic triglyceride decreased (Males; NC: 21.7±1.2, ALIOS: 16.7±1.1 mg/g. Females; NC: 18.5±0.7, ALIOS: 13.2±0.8 mg/g, P<0.05). ALIOS induced liver inflammation in both sexes and was associated with increased hepatic fibrosis (Male; NC: 3.2±0.5, ALIOS; 5.4±0.9%. Female; NC: 2.7±0.8, ALIOS: 5.9±1.1%, P<0.05). Advanced fibrotic liver disease increases the risk of HCC; ALIOS fed male mice were more prone to tumour development (NC: 7.7%, ALIOS: 22.2%, P<0.05), while there was no incidence of macroscopic tumours in females. The ALIOS diet in mice recapitulates many of the clinical features of NAFLD and represents a robust and reproducible model for investigating the pathogenesis of NAFLD and its progression to NASH and HCC.

Volume 65

Society for Endocrinology BES 2019

Brighton, United Kingdom
11 Nov 2019 - 13 Nov 2019

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.